| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.25 | 8e-12 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.34 | 3e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-06 |